Lates News

AstraZeneca CEO Soriot warned that, given the terms of the agreement reached with the Trump administration to lower drug costs for American patients, if higher drug prices cannot be guaranteed, this pharmaceutical giant may be forced to suspend the launch of new drugs in the UK and Europe. Soriot said that European countries must increase their investment in innovative drugs, otherwise this British-Swedish joint venture will have no choice but to almost entirely focus on the US market because nearly half of its revenue comes from the US.